antibiotics
A Charged Partnership: Unlikely Partners In The Antibiotics Arms Race
Antibiotic resistance is a growing threat to global health. By combining their expertise, a cancer drug delivery researcher and a technology giant might just have come up with a solution to prevent the slide into a post-antibiotic era.
MerLion’s Antibiotic Receives US FDA Approval
FDA approval for the otic suspension of finafloxacin paves the way for future Phase III trials for the injectable and oral forms.
MerLion’s Antibiotic Clears Phase II Trials
The new fluoroquinolone antibiotic has enhanced activity under acidic conditions, giving it an edge over existing antibiotics.
Newly Characterized Cells Could Treat Sepsis
Instead of antibiotics, doctors could use the patient's own immune cells to treat deadly sepsis in the future.
TaiGen’s Nemonoxacin Receives US FDA Fast Track Designation
TaiGen Biotech's nemonoxacin has received fast track designation and Qualified Infectious Disease Product status by the US FDA.
MicuRx Expands Clinical Trial Program For Oral Antibiotic MRX-I
MicuRx Pharmaceuticals has initiated a global clinical development program for its lead compound MRX-I.
MicuRx Raises US$25m For US-China Antibiotic Clinical Trial
MicuRx Pharma has raised US$25 million in Series B financing to carry out clinical trials on its MRX-I antibiotic candidate.
The Viet Nam Resistance Project Tackles Looming Antibiotic Crisis
Researchers are collaborating with 16 hospitals in Vietnam to strengthen national evidence-based control of antibiotic use in the country.
Gut Microbes Could Influence Survival In Melamine Scandal
Scientists have discovered a clue as to why some children survived the melamine-contaminated milk scandal in China.
